Attomole detection of 3H in biological samples using accelerator mass spectrometry:: Application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry

被引:39
作者
Dingley, KH [1 ]
Roberts, ML
Velsko, CA
Turteltaub, KW
机构
[1] Univ Calif Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94551 USA
[2] Univ Calif Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA
关键词
D O I
10.1021/tx9801458
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This is the first demonstration of the use of accelerator mass spectrometry (AMS) as a tool for the measurement of H-3 With attomole (10(-18) mol) sensitivity in a biological study. AMS is an analytical technique for quantifying rare isotopes with high sensitivity and precision and has been most commonly used to measure C-14 in both the geosciences and more recently in biomedical research. AMS measurement of serially diluted samples containing a H-3-labeled tracer showed a strong correlation with liquid scintillation counting. The mean coefficient of variation of H-3 AMS based upon the analysis of separately prepared aliquots of these samples was 12%. The sensitivity for H-3 detection in tissue, protein, and DNA was approximately 2-4 amol/mg of sample. This high sensitivity is comparable to detection limits for C-14-labeled carcinogens using C-14 AMS and demonstrates the feasibility of H-3 AMS for biomedical studies. One application of this technique is in low-dose, dual-isotope studies in conjunction with C-14 AMS. We measured the levels of H-3-labeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and C-14-labeled 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rat liver tissue and bound to liver DNA and protein 4.5 h following acute administration of individual or coadministered doses in the range of 4-5100 pmol/kg of body weight. Levels of PhIP and MeIQx in whole tissue and bound to liver protein were dose-dependent. MeIQx-protein and -DNA adduct levels were higher than PhIP adduct levels, which is consistent with their respective carcinogenicity in this organ. Coadministration of PhIP and MeIQx did not demonstrate any measurable synergistic effects compared to administration of these compounds individually. These studies demonstrate the application of AMS for the low-level detection of H-3 in small biological samples and for its use in conjunction with C-14 AMS for dual-labeling studies.
引用
收藏
页码:1217 / 1222
页数:6
相关论文
共 25 条
[1]   CRITERIA FOR ANALYZING INTERACTIONS BETWEEN BIOLOGICALLY-ACTIVE AGENTS [J].
BERENBAUM, MC .
ADVANCES IN CANCER RESEARCH, 1981, 35 :269-335
[2]   ACTIVATION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-BETA]PYRIDINE (PHIP) TO MUTAGENIC METABOLITES [J].
BUONARATI, MH ;
FELTON, JS .
CARCINOGENESIS, 1990, 11 (07) :1133-1138
[3]  
Dingley K. H., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P635
[4]  
Dingley KH, 1998, DRUG METAB DISPOS, V26, P825
[5]   DOSE-RESPONSE STUDIES OF MEIQX IN RAT-LIVER AND LIVER DNA AT LOW-DOSES [J].
FRANTZ, CE ;
BANGERTER, C ;
FULTZ, E ;
MAYER, KM ;
VOGEL, JS ;
TURTELTAUB, KW .
CARCINOGENESIS, 1995, 16 (02) :367-373
[6]   SYNERGISTIC ENHANCEMENT OF HEPATIC FOCI DEVELOPMENT BY COMBINED TREATMENT OF RATS WITH 10 HETEROCYCLIC AMINES AT LOW-DOSES [J].
HASEGAWA, R ;
MIYATA, E ;
FUTAKUCHI, M ;
HAGIWARA, A ;
NAGAO, M ;
SUGIMURA, T ;
ITO, N .
CARCINOGENESIS, 1994, 15 (05) :1037-1041
[7]   EXPOSURE TO COMPLEX-MIXTURES - IMPLICATIONS FOR BIOLOGICAL MONITORING [J].
IKEDA, M .
TOXICOLOGY LETTERS, 1995, 77 (1-3) :85-91
[8]   A NEW COLON AND MAMMARY CARCINOGEN IN COOKED FOOD, 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE (PHIP) [J].
ITO, N ;
HASEGAWA, R ;
SANO, M ;
TAMANO, S ;
ESUMI, H ;
TAKAYAMA, S ;
SUGIMURA, T .
CARCINOGENESIS, 1991, 12 (08) :1503-1506
[9]   ENHANCEMENT OF GST-P POSITIVE LIVER-CELL FOCI DEVELOPMENT BY COMBINED TREATMENT OF RATS WITH 5 HETEROCYCLIC AMINES AT LOW-DOSES [J].
ITO, N ;
HASEGAWA, R ;
SHIRAI, T ;
FUKUSHIMA, S ;
HAKOI, K ;
TAKABA, K ;
IWASAKI, S ;
WAKABAYASHI, K ;
NAGAO, M ;
SUGIMURA, T .
CARCINOGENESIS, 1991, 12 (05) :767-772
[10]  
KATO R, 1987, JPN J CANCER RES, V78, P297